Christoph Burkart
- Immunology top 10%
- interferon and immune responses 4
- Toxin Mechanisms and Immunotoxins 4
-
- Cardiomyopathy and Myosin Studies 4
- Cell Biology top 10%
- Oncology top 10%
- Cancer Diagnosis and Treatment 3
- Cytokine Signaling Pathways and Interactions 3
-
- Angiogenesis and VEGF in Cancer 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
-
- Microbial Inactivation Methods 3
Christoph Burkart
29 papers receiving 997 citations
Peers
Comparison fields: 5 of 82
- Immunology 295
- Cardiology and Cardiovascular Medicine 302
- Cell Biology 153
- Oncology 252
- Molecular Biology 501
Countries citing papers authored by Christoph Burkart
This map shows the geographic impact of Christoph Burkart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Burkart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Burkart more than expected).
Fields of papers citing papers by Christoph Burkart
This network shows the impact of papers produced by Christoph Burkart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Burkart. The network helps show where Christoph Burkart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christoph Burkart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2020 | 42 | |
| 5 | 2020 | 3 | |
| 6 | 2018 | 22 | |
| 7 | 2018 | 43 | |
| 8 | 2014 | 35 | |
| 9 | Intratympanale Dexamethasongabe: Nutzen in der Behandlung des hochgradigen Hörsturzes | 2013 | 2 |
| 10 | 2013 | 76 | |
| 11 | 2012 | 6 | |
| 12 | 2011 | 34 | |
| 13 | 2008 | 55 | |
| 14 | 2007 | 80 | |
| 15 | 2006 | 48 | |
| 16 | 2006 | 189 | |
| 17 | 2005 | 10 | |
| 18 | 2004 | 21 | |
| 19 | 2004 | 4 | |
| 20 | 2001 | 3 |
About Christoph Burkart
Christoph Burkart is a scholar working on Oncology, Immunology, Pharmacy, Biotechnology and Neurology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Cardiomyopathy and Myosin Studies (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Diagnosis and Treatment (3 papers), Microbial Inactivation Methods (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Immunology (295 citations), Cardiology and Cardiovascular Medicine (302 citations), Cell Biology (153 citations), Oncology (252 citations) and Molecular Biology (501 citations). Christoph Burkart has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Siegfried Labeit, D. Labeit, Mark McNabb, Henk Granzier, Christian Witt, Yiming Wu, Kei‐ichiro Arimoto, Dong‐Er Zhang, Belinda Bullard and Jun-Bao Fan. Their work appears in journals such as Journal of Clinical Oncology, Journal of Molecular Biology, Gene Therapy, Cancer Discovery and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.